ORG Wealth Partners LLC Grows Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

ORG Wealth Partners LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 45.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 771 shares of the healthcare conglomerate’s stock after buying an additional 241 shares during the period. ORG Wealth Partners LLC’s holdings in UnitedHealth Group were worth $405,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Capital & Planning LLC lifted its position in UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate’s stock valued at $248,000 after acquiring an additional 79 shares during the last quarter. Brighton Jones LLC increased its stake in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new stake in UnitedHealth Group during the fourth quarter worth $27,233,000. Revolve Wealth Partners LLC grew its position in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the period. Finally, Bank Pictet & Cie Europe AG grew its position in UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock valued at $133,373,000 after buying an additional 9,872 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer now owns 10,398 shares of the company’s stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders bought 109,408 shares of company stock worth $31,607,768 in the last 90 days. Corporate insiders own 0.28% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on UNH. Argus downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. Baird R W downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th. Royal Bank Of Canada decreased their price objective on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. Robert W. Baird downgraded shares of UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price target on the stock. in a research note on Wednesday, June 11th. Finally, TD Cowen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target on the stock. in a research note on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $426.52.

UnitedHealth Group Trading Down 0.6%

Shares of UNH stock opened at $306.90 on Thursday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $278.40 billion, a P/E ratio of 12.85, a price-to-earnings-growth ratio of 1.45 and a beta of 0.44. The company has a 50 day moving average price of $370.86 and a 200 day moving average price of $467.96. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter last year, the firm posted $6.91 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.88%. The ex-dividend date of this dividend is Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.